138 related articles for article (PubMed ID: 10568224)
41. Osteopenia in young hypogonadal women with systemic lupus erythematosus receiving chronic steroid therapy: a randomized controlled trial comparing calcitriol and hormonal replacement therapy.
Kung AW; Chan TM; Lau CS; Wong RW; Yeung SS
Rheumatology (Oxford); 1999 Dec; 38(12):1239-44. PubMed ID: 10587552
[TBL] [Abstract][Full Text] [Related]
42. Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study.
Gallagher JC; Goldgar D
Ann Intern Med; 1990 Nov; 113(9):649-55. PubMed ID: 2221645
[TBL] [Abstract][Full Text] [Related]
43. Combined treatment with calcitonin and 1,25-dihydroxyvitamin D3 for osteoporosis in women.
Eriksson SA; Lindgren JU
Calcif Tissue Int; 1993 Jul; 53(1):26-8. PubMed ID: 8348381
[TBL] [Abstract][Full Text] [Related]
44. Treatment of children with Osteogenesis imperfecta in Estonia.
Maasalu K; Haviko T; Märtson A
Acta Paediatr; 2003 Apr; 92(4):452-5. PubMed ID: 12801112
[TBL] [Abstract][Full Text] [Related]
45. Improved dosage form of the combined alendronate and calcitriol (Maxmarvil®) on the absorption of alendronate in Korean postmenopausal women.
Chung YS; Choi YJ; Kim SH
Arch Pharm Res; 2013 Aug; 36(8):966-72. PubMed ID: 23681426
[TBL] [Abstract][Full Text] [Related]
46. Effect of combined treatment with alendronate and calcitriol on femoral neck strength in osteopenic rats.
Nakamura Y; Naito M; Hayashi K; Fotovati A; Abu-Ali S
J Orthop Surg Res; 2008 Dec; 3():51. PubMed ID: 19091077
[TBL] [Abstract][Full Text] [Related]
47. Hypoparathyroidism unmasked by alendronate.
Kashyap AS; Kashyap S
Postgrad Med J; 2000 Jul; 76(897):417-8. PubMed ID: 10878202
[TBL] [Abstract][Full Text] [Related]
48. Calcitriol. A review of its use in the treatment of postmenopausal osteoporosis and its potential in corticosteroid-induced osteoporosis.
Dechant KL; Goa KL
Drugs Aging; 1994 Oct; 5(4):300-17. PubMed ID: 7827399
[TBL] [Abstract][Full Text] [Related]
49. Effect of long term treatment with calcitriol on calcium absorption and mineral metabolism in postmenopausal osteoporosis.
Riggs BL; Nelson KI
J Clin Endocrinol Metab; 1985 Sep; 61(3):457-61. PubMed ID: 3926808
[TBL] [Abstract][Full Text] [Related]
50. Combination Therapy of Raloxifene and Alendronate for Treatment of Osteoporosis in Elderly Women.
Um MJ; Cho EA; Jung H
J Menopausal Med; 2017 Apr; 23(1):56-62. PubMed ID: 28523260
[TBL] [Abstract][Full Text] [Related]
51. Calcium and calcitriol prophylaxis attenuates posttransplant bone loss.
Josephson MA; Schumm LP; Chiu MY; Marshall C; Thistlethwaite JR; Sprague SM
Transplantation; 2004 Oct; 78(8):1233-6. PubMed ID: 15502727
[TBL] [Abstract][Full Text] [Related]
52. Controversies in osteoporosis management: antiresorptive therapy for preventing bone loss: when to use one or two antiresorptive agents?
Gallagher JC; Tella SH
Clin Obstet Gynecol; 2013 Dec; 56(4):749-56. PubMed ID: 24036481
[TBL] [Abstract][Full Text] [Related]
53. Prevention of bone loss in kidney graft recipients.
Kovac D; Lindic J; Kandus A; Bren AF
Transplant Proc; 2001; 33(1-2):1144-5. PubMed ID: 11267228
[No Abstract] [Full Text] [Related]
54. The effects of calcitriol therapy on serum interleukin-1, interleukin-6 and tumour necrosis factor-alpha concentrations in post-menopausal patients with osteoporosis.
Inanir A; Ozoran K; Tutkak H; Mermerci B
J Int Med Res; 2004; 32(6):570-82. PubMed ID: 15587751
[TBL] [Abstract][Full Text] [Related]
55. Role of calcitriol in the treatment of postmenopausal osteoporosis.
Aloia JF
Metabolism; 1990 Apr; 39(4 Suppl 1):35-8. PubMed ID: 2182976
[TBL] [Abstract][Full Text] [Related]
56. Action of 1,25-dihydroxyvitamin D3 on calcium balance and bone turnover and its effect on vertebral fracture rate.
Gallagher JC; Riggs BL
Metabolism; 1990 Apr; 39(4 Suppl 1):30-4. PubMed ID: 2325569
[TBL] [Abstract][Full Text] [Related]
57. Calcitriol load test in postmenopausal osteoporosis: a pilot study.
Stefikova K; Spustova V; Krivosikova Z; Dzurik R
Bratisl Lek Listy; 2004; 105(5-6):211-4. PubMed ID: 15535112
[TBL] [Abstract][Full Text] [Related]
58. Metabolic effects of thiazide and 1,25-(OH)2 vitamin D in postmenopausal osteoporosis.
Sakhaee K; Zisman A; Poindexter JR; Zerwekh JE; Pak CY
Osteoporos Int; 1993 Jul; 3(4):209-14. PubMed ID: 8338977
[TBL] [Abstract][Full Text] [Related]
59. The response to calcitriol therapy in postmenopausal osteoporotic women is a function of initial calcium absorptive status.
Need AG; Morris HA; Horowitz M; Nordin BE
Calcif Tissue Int; 1997 Jul; 61(1):6-9. PubMed ID: 9192503
[TBL] [Abstract][Full Text] [Related]
60. New approach to osteopenia in phenylketonuric patients.
Pérez-Dueñas B; Cambra FJ; Vilaseca MA; Lambruschini N; Campistol J; Camacho JA
Acta Paediatr; 2002; 91(8):899-904. PubMed ID: 12222712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
